Cancer Genetics Inc (NASDAQ:CGIX)

Data as of Jan 23
 -0.25 / -3.13%
Today’s Change
Today|||52-Week Range
Health Services
Medical/Nursing Services

Company Description

Cancer Genetics, Inc. is an early-stage diagnostics company that engages in the development and commercializes proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. Its developments include DNA-FISH Probes, CGH Microarrays, and next-generation sequencing treatments. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Information

Cancer Genetics, Inc.
Meadows Office Complex
Rutherford New Jersey 07070
P:(201) 528-9200
Investor Relations:



Other institutional8.41%
Individual stakeholders21.57%
Mutual fund holders11.54%

Top Executives

Panna L. SharmaPresident, Chief Executive Officer & Director
Robert FannonVice President-Operations
Edward J. SitarChief Financial Officer, Secretary & Treasurer
Jane Houldsworth El NaggarVice President-Research & Development
Weiyi ChenDirector-Molecular Diagnostics

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.